Phase II Study of Chemoembolization With Drug-Eluting Beads in Patients With Hepatic Neuroendocrine Metastases: High Incidence of Biliary Injury
Bhagat N, Reyes D, Lin M, Kamel I, Pawlik T, Frangakis C, Geschwind J. Phase II Study of Chemoembolization With Drug-Eluting Beads in Patients With Hepatic Neuroendocrine Metastases: High Incidence of Biliary Injury. CardioVascular And Interventional Radiology 2012, 36: 449-459. PMID: 22722717, PMCID: PMC3596485, DOI: 10.1007/s00270-012-0424-y.Peer-Reviewed Original ResearchConceptsTransarterial chemoembolizationTumor sizeNeuroendocrine tumorsHigh incidenceNational Cancer Institute Common Terminology CriteriaEastern Cooperative Oncology Group statusHepatic neuroendocrine metastasesUnderwent percutaneous drainageCommon Terminology CriteriaObjective response ratePhase II studyPhase II trialMultiple small lesionsMethodsInstitutional review board approvalDrug-eluting beadsReview board approvalAlanine amino transferaseTerminology CriteriaAbdominal painBiliary injuryII trialDEB-TACEII studyEASL criteriaPercutaneous drainage